List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 485 studies with search of: "Treatment Experienced" [CONDITION] AND HIV [CONDITION]
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Not yet recruiting Therapeutic Intensification Plus Immunomodulation to Decrease the HIV-1 Viral Reservoir
Conditions: HIV Infections;   Treatment Experienced
Interventions: Biological: DNA + HIV-rAd5 vaccine;   Drug: ART intensification (raltegravir);   Drug: ART intensification (maraviroc)
2 Active, not recruiting A Study of Physical and Metabolic Abnormalities in HIV Infected and Uninfected Children and Youth
Conditions: HIV Infections;   HIV-Associated Lipodystrophy Syndrome;   HIV Lipodystrophy Syndrome;   Lipodystrophy;   Dyslipidemia;   Osteoporosis;   Osteopenia
Intervention:
3 Completed Evaluation of Effectiveness of Pharmaceutical Care on the Adherence of HIV-Positive Patients to Antiretroviral Therapy
Conditions: HIV;   HIV Infections
Intervention: Behavioral: pharmaceutical care
4 Active, not recruiting Treatment Simplification by Darunavir/Ritonavir 800/100 mg Once a Day Versus a Triple Combination Therapy With Darunavir/Ritonavir
Conditions: HIV Infections;   Human Immunodeficiency Virus;   Acquired Immunodeficiency Syndrome Virus;   AIDS Virus
Intervention: Drug: darunavir (DRV, TMC114)
5 Recruiting Pilot Study of a Raltegravir Based NRTI Sparing Regimen
Conditions: Acquired Immune Deficiency Syndrome;   AIDS;   Human Immunodeficiency Virus;   HIV Infections
Interventions: Drug: Raltegravir;   Drug: Atazanavir;   Other: Standard treatment regimen
6 Not yet recruiting Elizabeth Glaser Pediatric AIDS Foundation (EGPAF)Antiretroviral Pregnancy Registry A Multi-Site Protocol
Conditions: HIV Infections;   HIV Positive;   Pregnant Women
Intervention:
7 Recruiting Safety and Efficacy of Ampligen in the Treatment of HIV Patients Failing HAART
Conditions: HIV Seropositivity;   HIV Infection
Intervention: Drug: (Ampligen) polyI-polyC12U
8 Active, not recruiting Androgen Effects in HIV-Infected Women
Conditions: HIV Infection;   HIV Wasting Syndrome
Interventions: Drug: testosterone;   Drug: Placebo
9 Terminated Facial Lipoatrophy Trial: Immediate Versus Deferred Injections of Poly-L-Lactic Acid for HIV Facial Lipoatrophy
Conditions: HIV-Associated Lipodystrophy;   HIV Infections
Intervention: Device: poly-L-lactic acid
10 Recruiting Growth Hormone and/or Rosiglitazone for HIV-Associated Increased Abdominal Fat and Insulin Resistance
Conditions: HIV-Associated Lipodystrophy Syndrome;   Insulin Resistance;   HIV Infections;   Metabolic Syndrome X;   Body Weight Changes
Interventions: Drug: Recombinant Human Growth Hormone;   Drug: Rosiglitazone;   Drug: Recombinant Human Growth Hormone and Rosiglitazone;   Drug: Placebo human growth hormone and placebo rosiglitazone
11 Terminated Effect of Pioglitazone on HIV-1 Related Lipoatrophy: a Randomized, Double Blind, Placebo-Controlled Trial in 130 Patients
Conditions: HIV-Associated Lipodystrophy Syndrome;   HIV Infections
Intervention: Drug: Pioglitazone
12 Recruiting Effect of Diet-induced Weight Loss on HIV-associated Metabolic Syndrome
Conditions: HIV (Human Immunodeficiency Virus);   Metabolic Syndrome;   HIV Infections
Intervention: Behavioral: Dietary Intervention
13 Recruiting A Study to Assess the Pharmacokinetics (Blood Levels) of TMC114 (Darunavir) Taken With TMC114r (Ritonavir), and TMC125 (Etravirine) in HIV-1 Infected Pregnant Women
Conditions: HIV;   HIV Infections;   Pregnancy
Interventions: Drug: TMC114r (ritonavir);   Drug: TMC114 (darunavir);   Drug: TMC125 (etravirine)
14 Recruiting Seroprevalence of HSV-2 in HIV Infected Subjects and the Effect of Daily Valacyclovir in the Reduction of HSV-2 Recurrence and Viral Shedding
Conditions: HSV-2;   HIV;   HIV Infections
Interventions: Drug: Valacyclovir;   Drug: Placebo
15 Completed Evaluate Weight Gain Using 2 Different Formulations of Megestrol Acetate Oral Suspension for AIDS-Related Weight Loss
Conditions: HIV Infections;   Unintended Weight Loss;   Cachexia;   Anorexia;   AIDS Wasting Syndrome;   HIV Wasting Syndrome
Interventions: Drug: Megestrol acetate oral suspension nanocrystal dispersion 115 mg/mL;   Drug: Megestrol acetate oral suspension 40 mg/mL
16 Recruiting Effect Of An Integrase Inhibitor On The Latency And Reservoir Of HIV-1
Conditions: HIV-1;   HIV Infections
Intervention: Drug: Raltegravir
17 Recruiting Adjusting Antiretroviral Therapy Dosage Using Therapeutic Drug Monitoring
Conditions: Human Immunodeficiency Virus;   HIV Infections
Interventions: Drug: Reducing dose of Lopinavir;   Drug: Reducing dose of efavirenz
18 Recruiting Autologous T-Cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases SB-728 for HIV
Conditions: HIV;   HIV Infections
Interventions: Biological: ZFN modified T cells;   Other: Structured Treatment Interruption
19 Not yet recruiting Statin Therapy to Improve Atherosclerosis in HIV Patients
Conditions: Cardiovascular Disease;   HIV;   Atherosclerosis;   Inflammation;   Statins, HMG-CoA;   HIV Infections
Interventions: Drug: atorvastatin;   Drug: Placebo
20 Recruiting Evaluation of Three Strategies of Second-line Antiretroviral Treatment in Africa (Dakar - Bobo-Dioulasso - Yaoundé)
Conditions: HIV;   HIV Infections
Interventions: Drug: emtricitabine/tenofovir + lopinavir/ritonavir (WHO recommended second line);   Drug: abacavir + didanosine + lopinavir/ritonavir (WHO recommended second line);   Drug: emtricitabine/tenofovir + darunavir + ritonavir (Second line strategy under evaluation)

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options